A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect

O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIKE BROWNSTEIN, PETER LITERATI NAGI, JOZSEF MANDL, KALMAN TAKACS, KALMAN TORY, JESSE ROTH, GABOR BALOGH, ATTILA KOLONICS, ZOLTAN SZILVASSY, LASZLO VIGH, SANDOR BERNATH, JANOS EGRI, BALAZS SUMEGI
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.